Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland
TPMAT Recommendations - Round 30 (EOI Released February 2025)
Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes
Limo, J.; Pahe, C.; Kathure, I.; Ndungu, L.; Mahihu, A.; Mwashumbe, C.; Mueni, E. and Momanyi, H.
2025-01_QA Notice_USFDA Warning letter_Mylan Indore Pithampur site
Enhancing tuberculosis case notifications through mapping sales of medicine in the private sector: a quasi-experimental study in Punjab province, Pakistan
Beatrice Kirubi, Kinz Ul Eman, Usman R. Lodhi, Razia K. Fatima, Ghulam Nabi Kazi, Tahmeena Tahmeena, Syed Karam Shah and Jacob Creswell
ITB document ITB-Iplus/GDF-MED/2024/3
Annex L. TB medicines target prices ITB-Iplus/GDF-MED/2024/3
Annex K. Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2024/3
Annex J. Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2024/3
Annex I. GMSD address list ITB-Iplus/GDF-MED/2024/3
Pagination
- Page 1
- Next page